SG105539A1 - Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules - Google Patents

Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules

Info

Publication number: SG105539A1
Authority: SG; Singapore
Prior art keywords: microgranules; methylsulfinyl; pyrrol; benzimidazole; enteric
Prior art date: 2002-03-01

Application number

SG200201225A

Inventor

Kim Dong-Yeun

Park Dong-Woo

Lee Young-Jae

Original Assignee

Il Yang Pharm Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-01

Filing date

2002-03-01

Publication date

2004-08-27

2002-03-01 Application filed by Il Yang Pharm Co Ltd filed Critical Il Yang Pharm Co Ltd

2002-03-01 Priority to SG200201225A priority Critical patent/SG105539A1/en

2004-08-27 Publication of SG105539A1 publication Critical patent/SG105539A1/en

Links

AGUVFTCQOOFPFP-UHFFFAOYSA-N 1-methylsulfinyl-5-pyrrol-1-ylbenzimidazole Chemical compound C=1C=C2N(S(=O)C)C=NC2=CC=1N1C=CC=C1 AGUVFTCQOOFPFP-UHFFFAOYSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

SG200201225A 2002-03-01 2002-03-01 Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules SG105539A1 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
SG200201225A SG105539A1 (en)	2002-03-01	2002-03-01	Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SG200201225A SG105539A1 (en)	2002-03-01	2002-03-01	Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules

Publications (1)

Publication Number	Publication Date
SG105539A1 true SG105539A1 (en)	2004-08-27

Family

ID=33448795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200201225A SG105539A1 (en)	2002-03-01	2002-03-01	Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules

Country Status (1)

Country	Link
SG (1)	SG105539A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995023140A1 (en) *	1994-02-28	1995-08-31	Il-Yang Pharm. Co., Ltd.	Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
US6280773B1 (en) *	1998-12-29	2001-08-28	Il Yang Pharm. Co., Ltd.	Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative

2002
- 2002-03-01 SG SG200201225A patent/SG105539A1/en unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995023140A1 (en) *	1994-02-28	1995-08-31	Il-Yang Pharm. Co., Ltd.	Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
US6280773B1 (en) *	1998-12-29	2001-08-28	Il Yang Pharm. Co., Ltd.	Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative

Similar Documents

Publication	Publication Date	Title
PL374347A1 (en)	2005-10-17	Solid pharmaceutical formulations comprising telmisartan
TWI372066B (en)	2012-09-11	Pantoprazole multiparticulate formulations
SI1575618T1 (en)	2006-12-31	Dispersible pharmaceutical compositions
IL164519A0 (en)	2005-12-18	Pharmaceutical formulations
IL162404A0 (en)	2005-11-20	Stabilized formulations of adenovirus
EP1487417A4 (en)	2010-03-17	Dry powder medicament formulations
AU2003213151A1 (en)	2003-10-20	Controlled release solid dosage carbamazepine formulations
EG25453A (en)	2012-01-19	Deferacirox dispersible tablets
AP2004002969A0 (en)	2004-03-31	Stabilized oral suspension formulation.
IL164153A0 (en)	2005-12-18	Lansoprazole polymorphs and processes for preparation thereof
PL377495A1 (en)	2006-02-06	Solid drug for oral use
ZA200501084B (en)	2006-03-29	Dispersible tablets for oral administration
GB2392093B (en)	2006-03-08	Pharmaceutical formulations
EP1545476A4 (en)	2008-01-09	Chronotherapeutic diltiazem formulations and the administration thereof
IL148908A0 (en)	2002-09-12	Oral controlled release formulations
GB0218194D0 (en)	2002-09-11	Solid formulations
SG105539A1 (en)	2004-08-27	Stabilized enteric-coated microgranules comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl] methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole and oral formulations comprising the microgranules
PL393878A1 (en)	2011-05-09	Oral care agent containing ovomucin
EP1357898A4 (en)	2005-07-13	Improved controlled release oral dosage form
SG103334A1 (en)	2004-04-29	Tablet for oral administration comprising 2-[(4-methoxy-2-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole
ZA200803553B (en)	2009-04-29	Oral formulations comprising 3'-azidonucleosides
ZA200204905B (en)	2003-04-30	Improved pharmaceutical dental formulations.
AU2002368140A1 (en)	2004-02-23	Shape memory thermal exposure monitor
TW516760U (en)	2003-01-01	Plug-and-play digital recording monitor
GB2395068B (en)	2006-01-04	Solid state imager